Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-20

Clinical Trial Update: Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis

View source ↗

Summary

The study evaluated copeptin as a diagnostic biomarker for managing neurosurgical patients with disturbances in water balance related to pituitary adenoma. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Pituitary Adenoma | Status: COMPLETED